A Study to Evaluate the Effect of SAR443820 on Serum Neurofilament Levels in Male and Female Adult Participants With Multiple Sclerosis

Clinical trial NCT05630547 · TERMINATED

Trial details

NCT number: NCT05630547
Sponsor: Sanofi
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Multiple Sclerosis

Start date: 2022-12-19
Primary completion: 2024-11-21
Enrollment: 174

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.